Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
Jurynczyk M. et al, (2017), Acta Neuropathol Commun, 5
1H NMR-based metabolomics reveals neurochemical alterations in the brain of adolescent rats following acute methylphenidate administration.
Quansah E. et al, (2017), Neurochem Int, 108, 109 - 120
NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls.
Probert F. et al, (2017), Sci Rep, 7
Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
Jurynczyk M. et al, (2017), Brain, 140, 617 - 627
Ruiz-Rodado V. et al, (2016), J Proteome Res, 15, 3511 - 3527
One- and two-dimensional NMR investigations of the urinary excretion and metabolism of miglustat and valproate in patients with Niemann-Pick disease type C1
Grootveld M. et al, (2016), MOLECULAR GENETICS AND METABOLISM, 117, S52 - S52
Urinary excretion and metabolism of miglustat and valproate in patients with Niemann-Pick type C1 disease: One- and two-dimensional solution-state (1)H NMR studies.
Probert F. et al, (2016), J Pharm Biomed Anal, 117, 276 - 288
Loss of arylformamidase with reduced thymidine kinase expression leads to impaired glucose tolerance.
Hugill AJ. et al, (2015), Biol Open, 4, 1367 - 1375
Solution NMR analyses of the C-type carbohydrate recognition domain of DC-SIGNR protein reveal different binding modes for HIV-derived oligosaccharides and smaller glycan fragments.
Probert F. et al, (2013), J Biol Chem, 288, 22745 - 22757